ININSI (U.S. Trademark Serial Number 79196660) is a United States trademark of Boehringer Ingelheim International GmbH. The goods and services include: Publication of printed matter with the results of clinical studies involving pharmaceutical preparations Medical and scientific research in the fields of respiratory diseases and oncology; providing medical and scientific research information in the field of pharmaceuticals and clinical trials . The correspondent is Martin J. Beran of Ostrolenk Faber LLP.

This trademark was filed on October 13, 2016 as United States Trademark Application Serial Number 79196660. The trademark application was registered on July 04, 2017 as U.S. Trademark Registration 5234493.

Trademark PTO Status History

July 04, 2022 – COURTESY REMINDER – SEC. 71 (6-YR) E-MAILED

October 28, 2017 – FINAL DECISION TRANSACTION PROCESSED BY IB

October 10, 2017 – FINAL DISPOSITION NOTICE SENT TO IB

October 10, 2017 – FINAL DISPOSITION PROCESSED

October 04, 2017 – FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

July 04, 2017 – REGISTERED-PRINCIPAL REGISTER

April 18, 2017 – OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

April 18, 2017 – PUBLISHED FOR OPPOSITION

View full trademark status information at USPTO

Ownership History

Boehringer Ingelheim International GmbH

Boehringer Ingelheim International GmbH

Boehringer Ingelheim International GmbH

View documents on file at USPTO

File a Trademark or Get Help With Trademark Law

Select IP monitors top trademarks which have been allowed and granted worldwide. We are experts in trademark law. If you are interested in connecting with an IP law attorney or patent law attorney, please contact us via the contact form.